ADHD as a circadian rhythm disorder: evidence and implications for chronotherapy (2025)

Sleep and circadian rhythm interventions for ADHD are now recommended as a first-line treatment. If you have ADHD, routine screening for sleep disturbances and chronotype assessment will be part of your care.

Research published in Frontiers in Psychiatry suggests a significant link between Attention-Deficit/Hyperactivity Disorder (ADHD) and circadian rhythm dysfunction. A substantial subgroup of individuals with ADHD exhibit an evening chronotype and delayed biological markers, leading to profound sleep disturbances. Studies indicate that insomnia affects up to 82% of children and 80% of adults with ADHD, with delayed sleep-wake timing occurring in up to 78% of cases. Biological evidence includes delayed dim-light melatonin onset (DLMO) by approximately 45 minutes in children and 90 minutes in adults, along with blunted and delayed cortisol rhythms and attenuated peripheral clock-gene rhythms. Intervention studies using melatonin and bright light therapy have shown success in advancing DLMO and correlating with ADHD symptom improvement. Exercise and light-based protocols are also being explored as potential chronotherapeutic interventions.

The growing evidence framing ADHD as a circadian rhythm disorder implies a paradigm shift in treatment, moving beyond purely pharmacological or behavioral management of symptoms to directly addressing the underlying biological timing mechanisms. This perspective highlights the potential for chronotherapy, including melatonin and bright light interventions, to become standard adjunctive treatments for a significant portion of the ADHD population. The pragmatic, behavioral-first clinical pathway proposed suggests that screening for sleep and circadian issues, followed by targeted light and sleep hygiene interventions, will become routine. This approach offers a low-risk, scalable method to potentially improve core ADHD symptoms and overall functioning, warranting further research to define optimal protocols and identify specific responder phenotypes.

This reframing of ADHD necessitates a re-evaluation of diagnostic and therapeutic approaches within mental health and sleep medicine. It suggests that many sleep disturbances previously considered comorbidities might, in fact, be core manifestations of a dysregulated circadian system co-occurring with ADHD. The implication for clinicians is to integrate chronobiology assessments into their ADHD evaluations, moving towards a more personalized and biologically informed treatment strategy. For individuals with ADHD, this means a greater emphasis on sleep and wake schedules, light exposure timing, and potentially the use of light therapy or timed melatonin supplementation to help realign their internal biological clocks and alleviate symptoms.